infodiab
play

INFODIAB H E A LT H C O N S U LTAT I O N F O R P E O P L E W I T - PowerPoint PPT Presentation

INFODIAB H E A LT H C O N S U LTAT I O N F O R P E O P L E W I T H T Y P E 1 D I A B E T E S INFODIAB OUR MOTTO A D A P T T Y P E 1 D I A B E T E S A F T E R Y O U R L I F E S T Y L E & N O T T H E O T H E R WAY A R O U N


  1. INFODIAB H E A LT H C O N S U LTAT I O N F O R P E O P L E W I T H T Y P E 1 D I A B E T E S INFODIAB

  2. OUR MOTTO A D A P T T Y P E 1 D I A B E T E S A F T E R Y O U R L I F E S T Y L E & N O T T H E O T H E R WAY A R O U N D INFODIAB

  3. I N F O D I A B S H E A LT H C O N S U LTAT I O N I S B A S E D O N O U R L I F E S T Y L E M O D E L W E C A L L T H E C O G W H E E L P R I N C I P L E INFODIAB

  4. COGWHEEL PRINCIPLE BLOOD SUGAR REGULATION DIET EXERCISE MINDSET INFODIAB

  5. DIABETIC CHALLENGES H O R M O N E D I S T U R B A N C E W E A K E N E D E F F E C T O F I N S U L I N F L U C T U AT I N G E F F E C T O F I N S U L I N C O N S E Q U E N C E S O F H Y P E R G LY C E M I A C O N S E Q U E N C E S O F H Y P O G LY C E M I A F E A R O F H Y P O G LY C E M I A T H E R A P E U T I C C O - D E P E N D E N C E M O V E M E N T F E A R I D E N T I T Y C R I S I S D E P R E S S I O N A N X I E T Y INFODIAB

  6. WHAT WE DO I N D I V I D U A L B L O O D S U G A R R E G U L AT I O N S T R AT E G I E S I N D I V I D U A L - & L O W C A R B O H Y D R AT E D I E T S S T R E N G H T - & C A R D I O VA S C U L A R P E R S O N A L T R A I N I N G P S Y C H O S O C I A L S U P P O RT & U N D E R S TA N D I N G INFODIAB

  7. INFODIAB’S EXPERIENCE 2 0 1 6 – 2 0 1 7 R E S E A R C H I N G P H Y S I C A L E X E R C I S E A N D A 1 C I N S W E D I S H T Y P E 1 D I A B E T I C S AT M A L M Ö U N I V E R S I T Y H E A LT H C O N S U LTAT I O N C L I N I C I N M E D E O N S C I E N C E PA R K 2 0 1 7 – 2 0 1 8 L E C T U R I N G AT S TA D I O N M Ä S S A N & S T U D I E F Ö R B U N D E T V U X E N S K O L A N 2 0 1 8 M E M B E R S O F D I A B E T E S S A M V E R K A N O N L I N E E D U C AT I O N A L P L AT F O R M INFODIAB

  8. GET IN CONTACT D A N I E L @ I N F O D I A B . C O M W W W. I N F O D I A B . C O M @ I N F O D I A B S O C I A L M E D I A INFODIAB

  9. REFERENCES 1. Kukko, +. M., Kimpimaki, T., Korhonen, S., Kupila, A., Simell, S., Veijola, R., ... & Knip, M. (2005). Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population. The Journal of Clinical Endocrinology & Metabolism , 90(5), 2712-2717. 2. Kulmala, P., Savola, K., Petersen, J. S., Vähäsalo, P., Karjalainen, J., Löppönen, T., ... & Knip, M. (1998). Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. Journal of Clinical Investigation , 101 (2), 327. 3. Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014). Type 1 diabetes. The Lancet , 383(9911), 72. 4. American Diabetes Association. (2014). Diagnosis and classification of diabetes mellitus. Diabetes care , 37(Supplement 1), 87. 5. Misso, M. L., Egberts, K. J., Page, M., O'connor, D., & Shaw, J. (2010). Cochrane review: Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Evidence‐Based Child Health: A Cochrane Review Journal , 5 (4), 2. 6. Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., ... & SWITCH Study Group. (2012). The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia, 55(12), 3156. 7. Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001). Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. New England journal of medicine, 345(11), 790. 8. Wolfsdorf, J., Glaser, N., & Sperling, M. A. (2006). Diabetic ketoacidosis in infants, children, and adolescents. Diabetes care, 29(5), 1151-1154. 9. Barnard, K., Thomas, S., Royle, P., Noyes, K., & Waugh, N. (2010). Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review. BMC pediatrics, 10(1), 7. 10. Unger, R. H., & Cherrington, A. D. (2012). Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. The Journal of clinical investigation, 122(1), 4-11. 11. WHO. (2017). Physical activity. Available: http://www.who.int/mediacentre/factsheets/fs385/en/ Last visited 21 may, 2018. 12. Colberg, R.S., Sigal, J.R., Fernhall, B., Regensteiner, G.J., Blissmer, J.B, Rubin, R.R., Chasan-Taber, L., Albright, L.A., & Braun, B. (2010). Exercise and Type 2 Diabetes. Diabetes Care. 33 (12), 2692. 13. Folli, F., Saad, M. J., Backer, J. M., & Kahn, C. R. (1992). Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. Journal of Biological Chemistry , 267(31), 22171 - 22177. 14. Goodyear, L. J., Giorgino, F. R. A. N. C. E. S. C. O., Balon, T. W., Condorelli, G. E. R. O. L. A. M. A., & Smith, R. J. (1995). Effects of contractile activity on tyrosine phosphoproteins and PI 3-kinase activity in rat skeletal muscle. American Journal of Physiology-Endocrinology And Metabolism , 268(5), 987 - E995. 15. Greiwe, J. S., Hickner, R. C., Hansen, P. A., Racette, S. B., Chen, M. M., & Holloszy, J. O. (1999). Effects of endurance exercise training on muscle glycogen accumulation in humans. Journal of Applied Physiology , 87(1), 222-226. 16. McCoy, M. I. C. H. A. E. L., Proietto, J. O. S. E. P. H., & Hargreaves, M. A. R. K. (1996). Skeletal muscle GLUT-4 and postexercise muscle glycogen storage in humans . Journal of Applied Physiology , 80(2), 411-415. 17. Andersen, P., & Saltin, B. (1985). Maximal perfusion of skeletal muscle in man. The Journal of physiology , 366(1), 233-249. 18. Bouchonville, M., Jaghab, J., Duran-Valdez, E., Schrader, R., & Schade, D. (2014). The effectiveness and risks of programming an insulin pump to counteract the dawn phenomenon in type 1 diabetes. Endocrine Practice, 1-25. 19. Campbell, P. J., Bolli, G. B., Cryer, P. E., & Gerich, J. E. (1985). Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus: accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. New England Journal of Medicine, 312(23), 1473-1479. 20. Perriello, G., De Feo, P., Torlone, E., Fanelli, C., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1990). Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia, 33(1), 52-59. 21. Watson, J. M., Sherwin, R. S., Deary, I. J., Scott, L., & Kerr, D. (2003). Dissociation of augmented physiological, hormonal and cognitive responses to hypoglycaemia with sustained caffeine use. Clinical Science, 104(4), 447-454. 22. Watson, J. M., Jenkins, E. J., Hamilton, P., Lunt, M. J., & Kerr, D. (2000). Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes. Diabetes Care, 23(4), 455-459. 23. Fahey AJ, Paramalingam N, Davey RJ, Davis EA, Jones TW, Fournier PA. The effect of a short sprint on postexercise whole-body glucose production and utilization rates in individuals with type 1 diabetes mellitus. J Clin Endocrinol Metab 2012: 97: 4193 – 4200. 24. Turner, D., Luzio, S., Gray, B. J., Dunseath, G., Rees, E. D., Kilduff, L. P., ... & Bracken, R. M. (2015). Impact of single and multiple sets of resistance exercise in type 1 diabetes. Scandinavian journal of medicine & science in sports, 25(1), s 100 – 107. 25. Yuen KC, Chong LE, Riddle MC. Influence of glucocorticoids and growth hormone on insulin sensitivity in humans. Diabet Med 2013: 30: 651 – 663. 26. Howlett K, Galbo H, Lorentsen J, Bergeron R, Zimmerman-Belsing T, Bulow J, Feldt-Rasmussen U, Kjaer M. Effect of adrenaline on glucose kinetics during exercise in adrenalectomized humans. J Physiol 1999: 519 (Pt 3): 911 – 921. 27. Wasserman DH. Regulation of glucose fluxes during exercise in the postabsorptive state. Annu Rev Physiol 1995: 57: 191 – 218. 28. Watt MJ, Hargreaves M. Effect of epinephrine on glucose disposal during exercise in humans: role of muscle glycogen. Am J Physiol Endocrinol Metab 2002: 283: 578 – 583. 29. Black LE, Swan PD, Alvar BA. Effects of intensity and volume on insulin sensitivity during acute bouts of resistance training. J Strength Cond Res 2010: 24: 1109 – 1116. 30. Campbell MD, Walker M, Trenell MI, Jakovljevic DG, Stevenson EJ, Bracken RM, Bain SC, West DJ. Large pre- and postexercise rapid-acting insulin reductions preserve glycemia and prevents early- but not late-onset hypoglycemia in patients with type 1 diabetes. Diabetes Care 2013: 36 (8): 2217 – 2224. 31. Jentjens R, Jeukendrup A. Determinants of post-exercise glycogen synthesis during short-term recovery. Sports Med 2003: 33: 117 – 144. INFODIAB

  10. T H A N K Y O U F O R Y O U R T I M E INFODIAB

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend